IDL Diagnostics AB (OSTO:IDLDX) E10: kr-0.45 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:IDLDX IDL Diagnostics AB OSTO:IDLDX
55 GF Score
Price kr0.42
GF Value kr0.54
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is IDL Diagnostics AB E10?

IDL Diagnostics AB OSTO:IDLDX +3.69% 55 E10 is kr-0.45 as of Mar. 2026. GuruFocus rates OSTO:IDLDX with a GF Score™ of 55/100 and a GF Value™ of kr0.54 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

IDL Diagnostics AB's adjusted earnings per share data for the three months ended in Mar. 2026 was kr0.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-0.45 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of IDL Diagnostics AB was 27.40% per year. The lowest was 0.70% per year. And the median was 14.05% per year.

As of today (2026-07-15), IDL Diagnostics AB's current stock price is kr0.422. IDL Diagnostics AB's E10 for the quarter that ended in Mar. 2026 was kr-0.45. IDL Diagnostics AB's Shiller PE Ratio of today is .


IDL Diagnostics AB  (OSTO:IDLDX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


IDL Diagnostics AB E10 Related Terms


IDL Diagnostics AB E10 Historical Data

* Premium members only.

The historical data trend for IDL Diagnostics AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDL Diagnostics AB E10 Chart

IDL Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.34 -0.47 -0.49 0.00 -0.46

IDL Diagnostics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.48 -0.48 -0.47 -0.46 -0.45

OSTO:IDLDX vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, IDL Diagnostics AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDL Diagnostics AB Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Diagnostics AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IDL Diagnostics AB's Shiller PE Ratio falls into.


OSTO:IDLDX
55GF Score
IDL Diagnostics AB OSTO:IDLDX
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDL Diagnostics AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IDL Diagnostics AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.01/133.5600*133.5600
=0.010

Current CPI (Mar. 2026) = 133.5600.

IDL Diagnostics AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.066 101.019 -0.087
201609 -0.087 101.138 -0.115
201612 -0.062 102.022 -0.081
201703 -0.145 102.022 -0.190
201706 -0.122 102.752 -0.159
201709 -0.126 103.279 -0.163
201712 -0.194 103.793 -0.250
201803 -0.145 103.962 -0.186
201806 -0.164 104.875 -0.209
201809 -0.135 105.679 -0.171
201812 -0.135 105.912 -0.170
201903 -0.120 105.886 -0.151
201906 -0.118 106.742 -0.148
201909 -0.108 107.214 -0.135
201912 -0.157 107.766 -0.195
202003 -0.079 106.563 -0.099
202006 -0.079 107.498 -0.098
202009 -0.079 107.635 -0.098
202012 -0.063 108.296 -0.078
202103 -0.080 108.360 -0.099
202106 -0.090 108.928 -0.110
202109 -0.200 110.338 -0.242
202112 -0.190 112.486 -0.226
202203 -0.090 114.825 -0.105
202206 -0.070 118.384 -0.079
202209 -0.050 122.296 -0.055
202212 -0.080 126.365 -0.085
202303 -0.060 127.042 -0.063
202306 -0.070 129.407 -0.072
202309 -0.060 130.224 -0.062
202312 -0.070 131.912 -0.071
202403 -0.050 132.205 -0.051
202406 -0.060 132.716 -0.060
202409 0.000 132.304 0.000
202412 0.000 132.987 0.000
202503 -0.010 132.825 -0.010
202506 -0.060 133.699 -0.060
202509 -0.010 133.480 -0.010
202512 -0.010 133.390 -0.010
202603 0.010 133.560 0.010

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-0.45 mean?
IDL Diagnostics AB (OSTO:IDLDX) has a E10 of kr-0.45 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on IDL Diagnostics AB and its competitors.
Is IDL Diagnostics AB's E10 too high?
IDL Diagnostics AB's current E10 is kr-0.45. Overall, IDL Diagnostics AB has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDL Diagnostics AB's E10 compare to TMO and DHR?
IDL Diagnostics AB's E10 of kr-0.45 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on IDL Diagnostics AB and its competitors. IDL Diagnostics AB's current E10 is kr-0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDL Diagnostics AB stock overvalued right now?
Based on GuruFocus' analysis, IDL Diagnostics AB (OSTO:IDLDX) is currently considered Modestly Undervalued. The stock's GF Value™ is kr0.54, compared to a current price of kr0.42 — trading 21.9% below its estimated fair value. The current E10 is kr-0.45. IDL Diagnostics AB's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For IDL Diagnostics AB (OSTO:IDLDX), the current E10 is kr-0.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDL Diagnostics AB (OSTO:IDLDX) Overvalued in 2026?

Based on GuruFocus' analysis, IDL Diagnostics AB stock appears to be undervalued. The current stock price of kr0.42 is trading 21.9% below its estimated GF Value™ of kr0.54. GuruFocus considers IDL Diagnostics AB to be Modestly Undervalued.

Key valuation signals for OSTO:IDLDX:

  • E10: kr-0.45
  • GF Value™: kr0.54 vs. price of kr0.42 (21.9% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the OSTO:IDLDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IDL Diagnostics AB Business Description

Address Karlsbodavagen 39, Bromma, Stockholm, SWE, 168 67
IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. It specializes in oncology and bacteriology. The company has a broad product portfolio, is used in healthcare, and is established in various markets. In oncology, IDL Diagnostics uses various biomarkers, TK1 and cytokeratins, to support the treatment of cancers such as breast, prostate, and bladder cancers.
55GF Score

Get the complete analysis for OSTO:IDLDX

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.42
Price
kr0.54
GF Value